AdvisorShares Pure US Cannabis ETF News

Wall Street has experienced a robust upswing in May but few investing areas have fallen short of the broader market rally.

One of the hottest topics of the year has been cannabis stocks to buy, especially with elections nearing. We can see that with more than 88% of Americans wanting to see legalization.

Cannabis stocks to buy are rallying after the U.S. Department of Justice proposed reclassifying marijuana as a less risky Schedule III drug. Following the DOJ's proposal, President Biden came out

AdvisorShares Pure US Cannabis ETF invests in the cannabis industry through direct investments and derivatives. The top holdings of the ETF include Green Thumb Industries, Curaleaf Holdings, Trulieve

One of the more frustrating trades this year has been the back-and-forth rallies and sell offs in the cannabis sector. MSOS is the ETF stock ticker for US Cannabis.

Cannabis stocks are once again on the move today, with some big names being seen across the sector. Shares of Canopy Growth (NASDAQ: CGC ), Tilray (NASDAQ: TLRY ), Aurora Cannabis (NASDAQ: ACB ), Advi

Alex Carchidi is bullish on the cannabis sector but not ready to invest in stocks, except for Innovative Industrial Properties. 2 cannabis stocks worth considering are Green Thumb Industries and Truli

US President Joe Biden confirmed on Thursday that the Justice Department is officially moving toward reclassifying cannabis as a lower-risk drug. The Justice Department's proposed rule will soon be po

On this week's episode of ETF Prime, host Nate Geraci is joined by VettaFi Head of Research Todd Rosenbluth to discuss hedge funds embracing ETFs, spot ether ETFs, and a potential shortage of ETF tick

Looking at the ETFs with the highest returns YTD, a few thematic standouts have emerged.  As a reminder regarding  long-term investments, thematic investing is cyclical.

The U.S. pot sector could see an influx of medical research funding from healthcare investors amid renewed interest from pharmaceutical firms, should a proposal to reclassify cannabis as a lower-risk

Cannabis may be one of the most controversial investing topics. But, it's also turning out to be one of the most profitable.

There's growing optimism about marijuana reform after news that officials in the U.S. are looking to reschedule the substance. Canadian pot stocks may be the most popular ones to invest in, but multi-

Marijuana ETFs and cannabis stocks shot higher last week after the U.S. Justice Department said it plans to reclassify marijuana as a less dangerous drug.

New reported plans by the U.S. government could pave the pay for profit in marijuana investing. The White House is reportedly seeking to reclassify marijuana from a Schedule I drug to a Schedule III.